US Stock MarketDetailed Quotes

CHGCY Chugai Pharmaceutical (ADR)

Watchlist
  • 28.320
  • +0.130+0.46%
15min DelayClose Apr 29 15:59 ET
93.20BMarket Cap32.29P/E (TTM)

Chugai Pharmaceutical (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
21.74%288.46B
5.33%1.17T
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
Operating revenue
21.74%288.46B
5.33%1.17T
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
--273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
Cost of revenue
20.39%87.82B
-17.88%339.41B
-4.06%87.94B
-51.79%72.95B
-13.22%413.31B
92.06B
13.26%78.26B
14.83%91.66B
32.25%151.33B
40.84%476.25B
Gross profit
22.34%200.64B
19.07%831.2B
29.71%227.97B
1.92%164B
-10.90%698.06B
181.75B
15.02%179.64B
12.82%175.76B
-34.57%160.91B
18.42%783.48B
Operating expense
-0.22%63.99B
11.71%289.2B
10.31%69.65B
2.41%64.13B
3.49%258.89B
60.18B
23.02%72.96B
13.06%63.14B
6.30%62.62B
4.36%250.17B
Selling and administrative expenses
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
--30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
-1.89%100.48B
-Selling and marketing expense
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
--30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
31.18%100.48B
Research and development costs
-1.03%40.93B
3.76%181.44B
-3.66%42.94B
-3.53%41.36B
16.87%174.87B
--41.86B
24.15%45.57B
31.79%44.57B
26.58%42.87B
8.98%149.63B
Other operating expenses
-196.22%-178M
91.81%-2.34B
95.90%-603M
114.59%185M
-44,726.56%-28.56B
---12.44B
86.53%-160M
-1,203.82%-14.69B
-156.36%-1.27B
--64M
Operating profit
36.82%136.65B
23.41%542B
40.59%158.32B
1.60%99.87B
-17.65%439.17B
121.58B
10.11%106.69B
12.68%112.62B
-47.44%98.3B
26.41%533.31B
Net non-operating interest income expense
-5,580.00%-822M
-77.79%1.03B
-65.22%480M
-98.90%15M
51,733.33%4.65B
1.11B
142.48%788M
78.53%1.38B
-14.63%1.37B
-132.14%-9M
Non-operating interest income
-80.00%3M
--5M
-65.44%480M
-98.90%15M
----
----
----
76.27%1.39B
-15.24%1.37B
----
Non-operating interest expense
--825M
----
----
----
-55.74%27M
--8M
-53.33%7M
-40.00%9M
-85.71%2M
27.08%61M
Total other finance cost
----
78.03%-1.03B
----
----
-8,888.46%-4.67B
---1.12B
-143.21%-795M
----
----
31.58%-52M
Other net income (expense)
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
----
15.98%-2.13B
Income before tax
35.98%135.83B
22.35%543.03B
39.31%158.8B
0.23%99.89B
-16.44%443.82B
122.69B
13.09%107.48B
13.19%113.99B
-46.48%99.66B
26.65%531.17B
Income tax
51.42%38.6B
31.57%155.72B
52.40%46.94B
-2.57%25.49B
-24.49%118.35B
31.48B
9.80%29.9B
8.70%30.8B
-51.94%26.16B
34.67%156.74B
Net income
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Net income continuous Operations
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
--91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Minority interest income
Net income attributable to the parent company
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Basic earnings per share
30.67%29.545
18.99%117.695
34.43%33.99
1.21%22.61
-13.10%98.915
27.715
14.41%23.575
14.93%25.285
-44.25%22.34
23.52%113.82
Diluted earnings per share
30.68%29.54
18.99%117.68
34.43%33.985
1.21%22.605
-13.08%98.9
27.715
14.42%23.57
14.94%25.28
-44.23%22.335
23.57%113.785
Dividend per share
0
36.07%52.4022
14.37%22.7301
0
0.23%38.5119
18.6381
0
6.25%19.8738
0
4.41%38.4244
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 21.74%288.46B5.33%1.17T18.13%315.91B-24.11%236.95B-11.78%1.11T273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T
Operating revenue 21.74%288.46B5.33%1.17T18.13%315.91B-24.11%236.95B-11.78%1.11T--273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T
Cost of revenue 20.39%87.82B-17.88%339.41B-4.06%87.94B-51.79%72.95B-13.22%413.31B92.06B13.26%78.26B14.83%91.66B32.25%151.33B40.84%476.25B
Gross profit 22.34%200.64B19.07%831.2B29.71%227.97B1.92%164B-10.90%698.06B181.75B15.02%179.64B12.82%175.76B-34.57%160.91B18.42%783.48B
Operating expense -0.22%63.99B11.71%289.2B10.31%69.65B2.41%64.13B3.49%258.89B60.18B23.02%72.96B13.06%63.14B6.30%62.62B4.36%250.17B
Selling and administrative expenses 2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B--30.76B15.82%27.54B43.65%33.26B-7.77%21.02B-1.89%100.48B
-Selling and marketing expense 2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B--30.76B15.82%27.54B43.65%33.26B-7.77%21.02B31.18%100.48B
Research and development costs -1.03%40.93B3.76%181.44B-3.66%42.94B-3.53%41.36B16.87%174.87B--41.86B24.15%45.57B31.79%44.57B26.58%42.87B8.98%149.63B
Other operating expenses -196.22%-178M91.81%-2.34B95.90%-603M114.59%185M-44,726.56%-28.56B---12.44B86.53%-160M-1,203.82%-14.69B-156.36%-1.27B--64M
Operating profit 36.82%136.65B23.41%542B40.59%158.32B1.60%99.87B-17.65%439.17B121.58B10.11%106.69B12.68%112.62B-47.44%98.3B26.41%533.31B
Net non-operating interest income expense -5,580.00%-822M-77.79%1.03B-65.22%480M-98.90%15M51,733.33%4.65B1.11B142.48%788M78.53%1.38B-14.63%1.37B-132.14%-9M
Non-operating interest income -80.00%3M--5M-65.44%480M-98.90%15M------------76.27%1.39B-15.24%1.37B----
Non-operating interest expense --825M-------------55.74%27M--8M-53.33%7M-40.00%9M-85.71%2M27.08%61M
Total other finance cost ----78.03%-1.03B---------8,888.46%-4.67B---1.12B-143.21%-795M--------31.58%-52M
Other net income (expense)
Other non- operating income (expenses) ------------------------------------15.98%-2.13B
Income before tax 35.98%135.83B22.35%543.03B39.31%158.8B0.23%99.89B-16.44%443.82B122.69B13.09%107.48B13.19%113.99B-46.48%99.66B26.65%531.17B
Income tax 51.42%38.6B31.57%155.72B52.40%46.94B-2.57%25.49B-24.49%118.35B31.48B9.80%29.9B8.70%30.8B-51.94%26.16B34.67%156.74B
Net income 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Net income continuous Operations 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B--91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Minority interest income
Net income attributable to the parent company 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Basic earnings per share 30.67%29.54518.99%117.69534.43%33.991.21%22.61-13.10%98.91527.71514.41%23.57514.93%25.285-44.25%22.3423.52%113.82
Diluted earnings per share 30.68%29.5418.99%117.6834.43%33.9851.21%22.605-13.08%98.927.71514.42%23.5714.94%25.28-44.23%22.33523.57%113.785
Dividend per share 036.07%52.402214.37%22.730100.23%38.511918.638106.25%19.873804.41%38.4244
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 11.940
Sample Name
Sample Code
 27.600
Sample Name
Sample Code
 12.100
4
Workday
WDAY
243.390
5
eBay
EBAY
67.200
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 381.450
Sample Name
Sample Code
 292.030
Sample Name
Sample Code
 14.220
4
Meta Platforms
META
554.440
5
Salesforce
CRM
267.760
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 292.030
Sample Name
Sample Code
 1125.640
Sample Name
Sample Code
 91.170
4
Cisco
CSCO
57.340
5
Meta Platforms
META
554.440
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.4405
Sample Name
Sample Code
 2.110
Sample Name
Sample Code
 0.1650
4
BTCS Inc
BTCS
1.790
5
MARA Holdings
MARA
14.220
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -